Literature DB >> 23104662

Low values of left ventricular ejection time in the post-anhepatic phase may be associated with occurrence of primary graft dysfunction after orthotopic liver transplantation: results of a single-centre case-control study.

V Perilli1, P Aceto, C Modesti, P Ciocchetti, T Sacco, F Vitale, C Lai, S C Magalini, A W Avolio, L Sollazzi.   

Abstract

BACKGROUND: Previous investigations on risk factors for orthotopic liver transplantation (OLT) surgery have not analyzed hemodynamic aberrations in great detail. Moreover, the usefulness of esophageal Doppler monitoring has not been extensively studied in this clinical setting. The aim of this study was to evaluate if the occurrence of primary graft dysfunction (PGD) may be anticipated by hemodynamic indexes measured by esophageal Doppler (ED) monitoring system as well as by pulmonary artery catheter (PAC) in patients undergoing OLT.
MATERIALS AND METHODS: 38 OLT recipients were studied. Patients with acute liver failure or having non treated esophageal varices and those transplanted with marginal donors were excluded from the study. The haemodynamic data - measured by ED monitoring system (HemosonicTM 100, Arrow, OK, USA) and PAC - collected at the following 3 time points were considered for statistical analysis: 30 minutes after the induction of anesthesia but before skin incision, T0; 20 minutes after liver dissection, T1; at the beginning of biliary reconstruction, T2. On the basis of early outcome (72 hours after OLT), patients were distinguished into two groups: those with PGD (grade III-IV of Toronto classification) and those without PGD (grade I-II).
RESULTS: LVETc (left ventricular ejection time) values, registered at the beginning of biliary reconstruction (T2), were lower in patients with PGD compared to those without PGD (p < 0.000), while there were no differences in hemodynamic parameters derived from PAC between the two groups.
CONCLUSIONS: Since LVETc is related to preload, the results of this study would suggest that normovolemia could be the end point of a fluid replacement strategy in OLT setting.

Entities:  

Mesh:

Year:  2012        PMID: 23104662

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

Review 1.  Predictive factors of short term outcome after liver transplantation: A review.

Authors:  Giuliano Bolondi; Federico Mocchegiani; Roberto Montalti; Daniele Nicolini; Marco Vivarelli; Lesley De Pietri
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

2.  Human Urinary kallidinogenase promotes good recovery in ischemic stroke patients with level 3 hypertension.

Authors:  Danhong Wu; Yi Lyu; Ping Zhong; Fengdi Liu; Xueyuan Liu
Journal:  Brain Behav       Date:  2017-06-21       Impact factor: 2.708

Review 3.  Human urinary kallidinogenase combined with edaravone in treating acute ischemic stroke patients: A meta-analysis.

Authors:  Di-Xiao Yang; Yao Li; Dan Yu; Bi Guan; Qian Ming; Yan Li; Li-Qing Chen
Journal:  Brain Behav       Date:  2021-11-22       Impact factor: 2.708

4.  Extracellular histones are clinically associated with primary graft dysfunction in human liver transplantation.

Authors:  Xiuhui Li; Chunyan Gou; Yanhua Pang; Yakun Wang; Yan Liu; Tao Wen
Journal:  RSC Adv       Date:  2019-04-01       Impact factor: 4.036

5.  Effect of HUK on the outcome of ruptured intracranial aneurysm.

Authors:  Luyue Chen; Yi Lyu; Xiaoning Lin; Minghui Sun; Wei Feng; Xinhua Tian
Journal:  Brain Behav       Date:  2018-08-29       Impact factor: 2.708

6.  Human Urinary Kallidinogenase decreases recurrence risk and promotes good recovery.

Authors:  Dong Han; Xin Chen; Dongmei Li; Shuang Liu; Yi Lyu; Juan Feng
Journal:  Brain Behav       Date:  2018-07-20       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.